IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study

IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study

Background: Stem cell transplantation is emerging as a potential therapeutic strategy in several autoimmune diseases. However, the safety and feasibility of long-term combined intravenous (IV) and intrathecal (IT) administration of hUC-MSCs in relapse remitting multiple sclerosis (RRMS) and neuromye...

Full description

Bibliographic Details
Main Authors: Zhengjuan Lu, Lin Zhu, Zhuo Liu, Jiayong Wu, Yun Xu, Cun-Jin Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Neurology
Subjects:
human umbilical cord–derived mesenchymal stem cells
neuromyelitis optica
relapse remitting multiple sclerosis
safety
long-term follow-up
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00967/full

Similar Items

Similar Items